Another Reason for Dislike
These 10% moves are a little ridiculous these days. I have to tell you that the 10% move today in Bristol-Myers (BMY) was about as ridiculous as I have ever seen.
Yes, the big call on a big anti-Hep C drug might be off the table and investors have a fascination for anything that can beat Hep C. Bristol paid a couple of billion for a company that's working on one, so I get the disappointment. Plus, I have no doubt there will be more selling tomorrow because these 10% affairs have ALMOST ALWAYS brought out more sellers the next day. But at the same time, the yield is safe and the company's got a lot of irons in the fire as we said in the e-mails we sent out today before we bought the stock for Action Alerts PLUS....400 more words left in this article. To read them, just click below and try Real Money FREE for 14 days.
There’s no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.
Already a Subscriber? Please login.